VALENCIA, Calif. and MELBOURNE, Australia, June 16, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (RCEL) (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and ...

In both studies, upadacitinib met the coprimary endpoints of T-VASI 50 and F-VASI 75 at week 48 vs placebo. Topline data were announced from 2 replicate phase 3 studies evaluating upadacitinib in ...

Please provide your email address to receive an email when new articles are posted on . Repigmentation of at least 80% was achieved in 36% of areas treated with ASCS compared with 0% of control areas ...

In its second approval this month from the U.S. FDA, Avita Medical Inc.’s Recell system received premarket approval for the repigmentation of stable depigmented vitiligo lesions. The approval marks ...

AbbVie has submitted applications to the FDA and EMA for new indications for upadacitinib (RINVOQ 15-mg) for the treatment of adult and adolescent patients living with non-segmental vitiligo (NSV), ...

Adding twice-weekly narrowband UVB phototherapy to oral ritlecitinib may enhance response to treatment of nonsegmental vitiligo. Dual treatment was well-tolerated with no new safety signals in this ...

Ruxolitinib cream for vitiligo showed 60% of patients maintained benefits post-treatment, with potential for skin repigmentation upon reinitiation. JNJ-2113 demonstrated significant efficacy in plaque ...

In its second approval this month from the U.S. FDA, Avita Medical Inc.’s Recell system received premarket approval for the repigmentation of stable depigmented vitiligo lesions. The approval marks ...

AVITA Medical specializes in regenerative medicine and has an innovative device for skin restoration that treats full-thickness skin defects and vitiligo. The RECELL device uses a patient's skin cells ...

In a survey of pediatric patients with vitiligo, only 51.4% were offered narrowband ultraviolet B (NB-UVB) phototherapy, and 45.1% received this treatment before the age of 18 years. The main barriers ...

This article is sponsored by Incyte. Vitiligo is a chronic autoimmune condition that manifests as white patches of depigmented skin, or a complete loss of color, on affected areas of the body. The ...